{"Title": ["CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb", "Health Care Sector Update for 05/15/2020: TTPH,ACRX,LJPC,OMCL,OCUL,REGN,BPMC", "AcelRx Pharmaceuticals Inc (ACRX) Q1 2020 Earnings Call Transcript", "BUZZ-U.S. STOCKS ON THE MOVE-Facebook, Twitter, Valaris", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Valaris, QEP Resources", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Facebook, Valaris", "3 Compelling Penny Stocks With at Least 50% Upside Potential", "BNTX Soars On COVID-19 Alliance, DBVT Plunges, OPGN Jumps 101%, ACRX Buys TTPH", "CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb", "AcelRx Pharmaceuticals Inc (ACRX) Q3 2019 Earnings Call Transcript", "AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript", "3 Stocks Peter Lynch Would Love", "Why AcelRx Pharmaceuticals Stock Is Sinking Today", "Here's Why Momentum Investors Will Love AcelRx Pharmaceuticals (ACRX)", "3 Top Small-Cap Stocks to Buy Right Now", "Is AcelRx Pharmaceuticals (ACRX) Outperforming Other Medical Stocks This Year?", "AcelRx Pharmaceuticals Inc (ACRX) Q4 2019 Earnings Call Transcript", "3 Stocks to Hold for the Next 20 Years", "Health Care Sector Update for 11/09/2018: ACET, ACRX, NTRA, JNJ, PFE, ABT, MRK, AMGN", "Pre-Market Most Active for Nov 9, 2018 : GE, ACRX, FNSR, AMD, QQQ, AR, YELP, SQQQ, HSBC, BABA, AAPL, ACB", "Health Care Sector Update for 11/09/2018: JAZZ,ACRX,ACET,NTRA", "Health Care Sector Update for 11/09/2018: ACET,ACRX,NTRA", "Here's Why AcelRx Pharmaceuticals Lost as Much as 18.4% Today", "Why AcelRx Pharmaceuticals Stock Is Slipping Today", "2 Biotech Penny Stocks to Buy Right Now", "3 Stocks to Hold for the Next 20 Years", "Health Care Sector Update for 11/09/2018: ACET, ACRX, NTRA, JNJ, PFE, ABT, MRK, AMGN", "Are Options Traders Betting on a Big Move in AcelRx Pharmaceuticals (ACRX) Stock?", "4 Strong Buy Biotech Stocks With Upcoming FDA Decisions", "3 Biotechs Awaiting FDA Approval Decisions", "Mid-Day Update: Wall Street Continues to Struggle as Geopolitical Tensions, Market Sell-Off Weighs", "Pre-Market Most Active for Nov 5, 2018 : AAPL, GE, ACRX, CHK, TEVA, GGB, AMD, QQQ, SQQQ, LYG, NVS, TQQQ", "3 Big Stock Charts for Monday: Coca-Cola, Kinder Morgan and Adobe", "AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates", "Will AcelRx Pharmaceuticals (ACRX) Report Negative Earnings Next Week? What You Should Know", "Are Options Traders Betting on a Big Move in AcelRx Pharmaceuticals (ACRX) Stock?", "Here's Why AcelRx Pharmaceuticals, Inc. Fell 11.5% on Tuesday", "Here's Why AcelRx Pharmaceuticals, Inc. Jumped 16.5% on Monday", "Health Care Sector Update for 09/11/2018: ACRX, XENE, INCY, KMPH, IMV", "Why AcelRx Pharmaceuticals Inc. Is Jumping Today", "CTI BioPharma Tanks Post Type B Talks on Pacritinib With FDA", "Mid-Morning Market Update: Markets Open Higher; Delta Air Lines Earnings Beat Estimates", "Mid-Morning Market Update: Markets Open Higher; Delta Air Lines Earnings Beat Estimates", "Health Care Sector Update for 07/12/2018: AUPH,AUP.TO,MYOV,ACRX", "Health Care Sector Update for 07/12/2018: AGIO,XENE,AUPH,AUP.TO,MYOV,ACRX", "Health Care Sector Update for 07/12/2018: XENE,AUPH,AUP.TO,MYOV,ACRX", "Pacira (PCRX) Issues Strong Preliminary Exparel Sales for Q2", "Is AcelRx Pharmaceuticals (ACRX) Outperforming Other Medical Stocks This Year?", "Aclaris' Alopecia Candidate Gets Fast Track Designation", "Shire (SHPG) HAE Drug Gets FDA Nod for Pediatric Population", "Small Drugmakers Edging Out the Bigshots: 7 Stocks to Buy", "Top Ranked Momentum Stocks to Buy for June 15th", "Pre-Market Most Active for May 24, 2018 : AGNC, PBR, BP, BBY, DB, MLNT, TVIX, MU, GE, CHK, QQQ, ACRX", "Health Care Sector Update for 05/24/2018: ATHN,CELG,ACRX,KPTI", "Health Care Sector Update for 05/24/2018: CELG,ACRX,KPTI", "VIVUS' PAH Candidate Data Positive in Early Stage Study", "Wall Street Sees Mixed Open; US GDP Climbs More Than Expected in Q1", "US Futures Mixed Ahead of US GDP Reading", "Earnings Reaction History: AcelRx Pharmaceuticals, Inc., 66.7% Follow-Through Indicator, 10.4% Sensitive", "Are Options Traders Betting on a Big Move in AcelRx Pharmaceuticals (ACRX) Stock?", "Omeros Inks Agreement With FDA for OMS721 Phase III Trial", "Trevena Announces FDA Acceptance of Olinvo NDA, Shares Up", "Merck's Keytruda Gets Approved for Bladder Cancer in Japan", "Top Ranked Momentum Stocks to Buy for May 18th", "Actinium Posts Positive DMC View on Lomab-B Phase III Trial", "Health Care Sector Update for 10/20/2017: QURE, ACRX, DRRX", "Health Care Sector Update for 10/20/2017: CELG,ACRX,DRRX", "AcelRx's Opioid Painkiller Dsuvia Gets CRL, Shares Plunge", "Mid-Day Market Update: J.Jill Tumbles Following Weak Q3 Outlook; Ardelyx Shares Surge", "Mid-Morning Market Update: Markets Edge Lower; JPMorgan Profit Beats Estimates", "Pre-Market Most Active for Oct 12, 2017 : MU, AZN, ACRX, ARDX, INFI, JILL, BAC, C, GSK, SNAP, MNKD, TVIX", "5 Reasons to Pick Emergent as an Investment-Worthy Stock", "Health Care Sector Update for 10/12/2017: ARDX,INFI,ACRX", "Why AcelRx Pharmaceuticals Inc Got Cut in Half Today", "Dow Returns to All-Time Highs", "AcelRx Pharmaceuticals (ACRX) in Focus: Stock Moves 19.6% Higher", "3 Biotech and Pharma Stocks with Key FDA Catalysts this October", "Why AcelRx Pharmaceuticals Inc Jumped Higher Today", "Implied Volatility Surging for AcelRx Pharmaceuticals (ACRX) Stock Options", "Health Care Sector Update for 10/12/2017: AMPE,INFI,ACRX", "Tuesday Sector Laggards: Trucking, Drugs", "Monday Sector Leaders: Biotechnology, Drugs", "Pre-Market Most Active for Jul 17, 2017 : DDC, SNY, ACRX, NVDA, BAC, TVIX, BABA, RAD, MU, APRN, AAPL, NTNX", "Health Care Sector Update for 07/17/2017: CBAY,ACRX,RPRX", "Health Care Sector Update for 07/17/2017: PPHM,ACRX,RPRX", "5 Biotech Stocks With Major Catalysts in July", "Mid-Day Market Update: Dow Drops Over 100 Points; Arena Pharmaceuticals Shares Plummet", "Pre-Market Most Active for Aug 1, 2017 : MBLY, UAA, UA, NOK, MCHI, ACRX, S, BP, USLV, QQQ, TVIX, AAPL", "Tuesday Sector Laggards: Trucking, Drugs", "Company News for September 16, 2016", "Stock Futures Trim Gains as Econ Data Fails to Extinguish Rate Hike Jitters", "Pre-Market Most Active for Sep 15, 2016 : AEG, AAPL, AZN, AERI, XIV, QQQ, ACRX, TTM, BAC, TVIX, NOK, CS", "Pre-Market Most Active for Aug 15, 2016 : BABA, AUPH, YHOO, TWTR, CHK, VRX, X, TWLO, ACRX, XIV, ACIA, AAPL", "Health Care Sector Update for 08/15/2016: ACRX, ADK, JNJ, PFE, ABT, MRK, AMGN", "Friday Sector Leaders: Drugs, Hospital & Medical Practitioners", "AcelRx Pharmaceuticals (ACRX) in Focus: Stock Jumps 5.3%", "AcelRx Pharmaceuticals (ACRX): Strong Industry, Solid Earnings Estimate Revisions", "Health Care Sector Update for 03/08/2016: OMER,BNTC,ACRX", "Health Care Sector Update for 03/08/2016: CDNA, BNTC, ACRX", "Earnings Reaction History: AcelRx Pharmaceuticals, Inc., 100.0% Follow-Through Indicator, 23.9% Sensitive", "Health Care Sector Update for 01/21/2016: AGIO, ACRX", "AcelRx Updates on Zalviso for Pain Management Treatment", "U.S. Equities Set For Positive Start To Trading Week", "AcelRx Pharmaceuticals (ACRX) in Focus: Stock Jumps 5.3%", "New Strong Buy Stocks for September 29th", "Why Valeant's (VRX) Shares Plummeted in Monday Trading", "PDL BioPharma Concludes Financing Agreement with Avinger", "Valeant's Glaucoma Drug Accepted for Review by the FDA", "AcelRx's Pain Treatment Drug Zalviso Approved in Europe", "PDL BioPharma to Get Royalties on AcelRx's Zalviso Sales", "New Strong Buy Stocks for October 1st", "Pre-Market Most Active for Sep 9, 2015 : TTPH, YHOO, AAPL, ACRX, XIV, ALU, BABA, TVIX, BAC, SUNE, BHP, NOK", "Health Care Sector Update for 09/09/2015: RDHL, AST, ACRX", "Why AceIRx (ACRX) Could Be a Potential Winner", "BioCryst Pharmaceuticals (BCRX) Jumps: Stock Rises 12.5% - Tale of the Tape", "Concert Pharmaceuticals (CNCE) in Focus: Stock Rises 5.2% - Tale of the Tape", "New Strong Buy Stocks for August 4th - Tale of the Tape", "Notable ETF Outflow Detected - BIB, ACAD, XLRN, ACRX", "Why You Shouldn't Bet Against AceIRx Pharmaceuticals (ACRX) Stock", "Can the Rally in AcelRx Pharmaceuticals (ACRX) Shares Continue? - Tale of the Tape", "AcelRx Pharmaceuticals (ACRX) Looks Good: Stock Up 8% - Tale of the Tape", "Health Care Sector Update for 05/14/2015: ACRX, DSCO, EPRS", "Tuesday Sector Laggards: Drugs, Paper & Forest Products", "AcelRx Starts Pivotal Study on Acute Pain Management Drug - Analyst Blog", "Health Care Sector Update for 03/16/2015: NBY, SLXP, ACRX", "Health Care Sector Update for 03/10/2015: ACRX, VRX, RDUS", "Health Care Sector Update for 07/02/2015: NAVB, AMSG, ACRX", "Why AcelRx Pharmaceuticals, Inc. Stock Got Crushed", "Why The Medicines Company Is Tumbling", "After-Hours Earnings Report for March 9, 2015 : URBN, QIHU, UNFI, CASY, MR, KFY, VNET, XOXO, ACRX, WPRT, LMNR, BRSS", "Should You Sell AcelRx Pharmaceuticals (ACRX) Before Earnings? - Tale of the Tape", "Health Care Sector Update for 02/26/2015: MACK, MGLN, ACRX", "AcelRx (ACRX) Shares March Higher, Can It Continue? - Tale of the Tape", "Why AcelRx Pharmaceuticals Inc. Is Crashing", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "La Jolla Pharmaceutical (LJPC) Jumps: Stock Gains 5.8% - Tale of the Tape", "Health Care Sector Update for 12/02/2014: GWPH, ACRX, GALE", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Minerva Neurosciences (NERV) in Focus: Stock Jumps 8.2% - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "AcelRx Pharmaceuticals (ACRX) Soars: Stock Adds 6.8% in Session - Tale of the Tape", "Pre-Market Most Active for Jul 28, 2014 : FDO, DLTR, ACRX, HZNP, TRLA, LOCO, SNY, DG, BHP, GSK, FB, AAPL", "Monday Sector Laggards: Metals Fabrication & Products, Drugs", "AcelRx Pharmaceuticals (ACRX) Jumps: Stock Adds 11.7% in Session - Tale of the Tape", "Friday Sector Leaders: Manufacturing, Drugs", "Mid-Morning Market Update: Markets Edge Lower; D.R. Horton Posts Downbeat Profit", "Zacks Rank #1 Additions for Tuesday - Tale of the Tape", "ArQule (ARQL) Catches Eye: Stock Jumps 10.4% - Tale of the Tape", "AcelRx Pharmaceuticals (ACRX) Soars: Stock Adds 6.8% in Session - Tale of the Tape", "Pre-Market Most Active for Jul 28, 2014 : FDO, DLTR, ACRX, HZNP, TRLA, LOCO, SNY, DG, BHP, GSK, FB, AAPL", "Monday Sector Laggards: Metals Fabrication & Products, Drugs", "AcelRx Pharmaceuticals (ACRX) Jumps: Stock Up 17.9% - Tale of the Tape", "AcelRx Pharmaceuticals (ACRX) Jumps: Stock Rises 9.0% - Tale of the Tape", "Insider Trading: Sales at Google, Facebook, and Whole Foods; Buys at Agco and Vivus", "Insider Trading: Buys at Freeport-McMoRan, Horsehead Holding, AcelRx", "AcelRx Gives Patent Update - Analyst Blog", "After-Hours Earnings Report for August 12, 2013 : SINA, TRQ, IOC, IAG, WX, HMIN, TWGP, EGL, CCXI, FN, NQ, ACRX", "In Insider Trading, Apollo Management Group Makes Two Major Sales, While eBay Sees a Purchase", "Pre-Market Most Active for May 21, 2013 : JASO, MSFT, SDBT, AMAT, ACRX, CSIQ", "After-Hours Earnings Report for March 12, 2013 : KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN, ACRX, FOLD, GCAP", "NDA for AcelRx's Zalviso Accepted - Analyst Blog", "Synergy/Callisto Merger Approved - Analyst Blog", "FDA Approval for Santarus' Uceris - Analyst Blog"], "Elapsed Time": ["JUN 4, 2020", "MAY 15, 2020", "MAY 12, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 16, 2020", "MAR 16, 2020", "JUN 4, 2020", "NOV 6, 2019", "AUG 5, 2019", "APR 29, 2019", "MAR 8, 2019", "MAR 8, 2019", "MAR 4, 2019", "FEB 11, 2019", "MAR 16, 2020", "DEC 1, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 9, 2018", "NOV 5, 2018", "DEC 27, 2018", "DEC 1, 2018", "NOV 9, 2018", "OCT 26, 2018", "OCT 23, 2018", "OCT 16, 2018", "OCT 15, 2018", "NOV 5, 2018", "NOV 5, 2018", "NOV 2, 2018", "NOV 1, 2018", "OCT 26, 2018", "OCT 2, 2018", "SEP 24, 2018", "SEP 11, 2018", "OCT 15, 2018", "JUL 19, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 12, 2018", "JUL 11, 2018", "AUG 9, 2018", "JUL 10, 2018", "JUN 22, 2018", "JUN 19, 2018", "JUN 15, 2018", "MAY 24, 2018", "MAY 24, 2018", "MAY 24, 2018", "JUL 11, 2018", "APR 27, 2018", "APR 27, 2018", "MAR 8, 2018", "MAR 7, 2018", "JAN 4, 2018", "JAN 3, 2018", "JAN 3, 2018", "MAY 18, 2018", "DEC 28, 2017", "OCT 20, 2017", "OCT 20, 2017", "OCT 13, 2017", "OCT 12, 2017", "OCT 12, 2017", "OCT 12, 2017", "JAN 3, 2018", "OCT 12, 2017", "OCT 12, 2017", "OCT 11, 2017", "OCT 3, 2017", "OCT 2, 2017", "OCT 2, 2017", "SEP 26, 2017", "OCT 12, 2017", "AUG 1, 2017", "JUL 24, 2017", "JUL 17, 2017", "JUL 17, 2017", "JUL 17, 2017", "JUN 28, 2017", "APR 18, 2017", "AUG 1, 2017", "AUG 1, 2017", "SEP 16, 2016", "SEP 15, 2016", "SEP 15, 2016", "AUG 15, 2016", "AUG 15, 2016", "MAR 3, 2017", "AUG 4, 2016", "APR 12, 2016", "MAR 8, 2016", "MAR 8, 2016", "MAR 7, 2016", "JAN 21, 2016", "OCT 8, 2015", "AUG 15, 2016", "AUG 4, 2016", "SEP 29, 2015", "SEP 29, 2015", "SEP 24, 2015", "SEP 23, 2015", "SEP 23, 2015", "SEP 22, 2015", "OCT 1, 2015", "SEP 9, 2015", "SEP 9, 2015", "AUG 21, 2015", "AUG 11, 2015", "AUG 6, 2015", "AUG 4, 2015", "JUL 21, 2015", "SEP 10, 2015", "JUN 3, 2015", "MAY 15, 2015", "MAY 14, 2015", "MAY 5, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 10, 2015", "JUL 2, 2015", "MAR 9, 2015", "MAR 9, 2015", "MAR 9, 2015", "MAR 6, 2015", "FEB 26, 2015", "JAN 12, 2015", "MAR 10, 2015", "JAN 5, 2015", "DEC 29, 2014", "DEC 18, 2014", "DEC 15, 2014", "DEC 15, 2014", "DEC 2, 2014", "NOV 20, 2014", "JAN 7, 2015", "JAN 5, 2015", "NOV 11, 2014", "AUG 1, 2014", "JUL 28, 2014", "JUL 28, 2014", "JUL 21, 2014", "JUL 18, 2014", "NOV 11, 2014", "NOV 11, 2014", "NOV 11, 2014", "AUG 1, 2014", "JUL 28, 2014", "JUL 28, 2014", "DEC 17, 2013", "JUN 17, 2014", "NOV 13, 2013", "NOV 5, 2013", "OCT 9, 2013", "AUG 12, 2013", "JUL 25, 2013", "MAY 21, 2013", "MAR 12, 2013", "DEC 5, 2013", "JAN 17, 2013", "JAN 18, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/cycn-awaits-sickle-cell-disease-data-ttph-finalizes-its-suitor-adms-faces-fda-in-feb-2020", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-15-2020%3A-ttphacrxljpcomcloculregnbpmc-2020-05-15", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-inc-acrx-q1-2020-earnings-call-transcript-2020-05-12", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-facebook-twitter-valaris-2020-04-30", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-valaris-qep-resources-2020-04-30", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-facebook-valaris-2020-04-30", "https://www.nasdaq.com/articles/3-compelling-penny-stocks-with-at-least-50-upside-potential-2020-04-16", "https://www.nasdaq.com/articles/bntx-soars-on-covid-19-alliance-dbvt-plunges-opgn-jumps-101-acrx-buys-ttph-2020-03-16", "https://www.nasdaq.com/articles/cycn-awaits-sickle-cell-disease-data-ttph-finalizes-its-suitor-adms-faces-fda-in-feb-2020", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-inc-acrx-q3-2019-earnings-call-transcript-2019-11-07", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-inc-acrx-q2-2019-earnings-call-transcript-2019-08-06", "https://www.nasdaq.com/articles/3-stocks-peter-lynch-would-love-2019-04-29", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-stock-sinking-today-2019-03-08", "https://www.nasdaq.com/articles/heres-why-momentum-investors-will-love-acelrx-pharmaceuticals-acrx-2019-03-08", "https://www.nasdaq.com/articles/3-top-small-cap-stocks-buy-right-now-2019-03-04", "https://www.nasdaq.com/articles/is-acelrx-pharmaceuticals-acrx-outperforming-other-medical-stocks-this-year-2019-02-11", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-inc-acrx-q4-2019-earnings-call-transcript-2020-03-16", "https://www.nasdaq.com/articles/3-stocks-hold-next-20-years-2018-12-01", "https://www.nasdaq.com/articles/health-care-sector-update-11092018-acet-acrx-ntra-jnj-pfe-abt-mrk-amgn-2018-11-09", "https://www.nasdaq.com/articles/pre-market-most-active-nov-9-2018-ge-acrx-fnsr-amd-qqq-ar-yelp-sqqq-hsbc-baba-aapl-acb", "https://www.nasdaq.com/articles/health-care-sector-update-11092018-jazzacrxacetntra-2018-11-09", "https://www.nasdaq.com/articles/health-care-sector-update-11092018-acetacrxntra-2018-11-09", "https://www.nasdaq.com/articles/heres-why-acelrx-pharmaceuticals-lost-much-184-today-2018-11-09", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-stock-slipping-today-2018-11-05", "https://www.nasdaq.com/articles/2-biotech-penny-stocks-buy-right-now-2018-12-27", "https://www.nasdaq.com/articles/3-stocks-hold-next-20-years-2018-12-01", "https://www.nasdaq.com/articles/health-care-sector-update-11092018-acet-acrx-ntra-jnj-pfe-abt-mrk-amgn-2018-11-09", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-acelrx-pharmaceuticals-acrx-stock-2018-10-26", "https://www.nasdaq.com/articles/4-strong-buy-biotech-stocks-upcoming-fda-decisions-2018-10-23", "https://www.nasdaq.com/articles/3-biotechs-awaiting-fda-approval-decisions-2018-10-16", "https://www.nasdaq.com/articles/mid-day-update-wall-street-continues-struggle-geopolitical-tensions-market-sell-weighs", "https://www.nasdaq.com/articles/pre-market-most-active-nov-5-2018-aapl-ge-acrx-chk-teva-ggb-amd-qqq-sqqq-lyg-nvs-tqqq-2018", "https://www.nasdaq.com/articles/3-big-stock-charts-for-monday%3A-coca-cola-kinder-morgan-and-adobe-2018-11-05", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-reports-q3-loss-misses-revenue-estimates-2018-11-02", "https://www.nasdaq.com/articles/will-acelrx-pharmaceuticals-acrx-report-negative-earnings-next-week-what-you-should-know", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-acelrx-pharmaceuticals-acrx-stock-2018-10-26", "https://www.nasdaq.com/articles/heres-why-acelrx-pharmaceuticals-inc-fell-115-tuesday-2018-10-02", "https://www.nasdaq.com/articles/heres-why-acelrx-pharmaceuticals-inc-jumped-165-monday-2018-09-24", "https://www.nasdaq.com/articles/health-care-sector-update-09112018-acrx-xene-incy-kmph-imv-2018-09-11", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-inc-jumping-today-2018-10-15", "https://www.nasdaq.com/articles/cti-biopharma-tanks-post-type-b-talks-on-pacritinib-with-fda-2018-07-19", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-delta-air-lines-earnings-beat-estimates-2018", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-higher-delta-air-lines-earnings-beat-estimates-0", "https://www.nasdaq.com/articles/health-care-sector-update-07122018-auphauptomyovacrx-2018-07-12", "https://www.nasdaq.com/articles/health-care-sector-update-07122018-agioxeneauphauptomyovacrx-2018-07-12", "https://www.nasdaq.com/articles/health-care-sector-update-07122018-xeneauphauptomyovacrx-2018-07-12", "https://www.nasdaq.com/articles/pacira-pcrx-issues-strong-preliminary-exparel-sales-for-q2-2018-07-11", "https://www.nasdaq.com/articles/is-acelrx-pharmaceuticals-acrx-outperforming-other-medical-stocks-this-year-2018-08-09", "https://www.nasdaq.com/articles/aclaris-alopecia-candidate-gets-fast-track-designation-2018-07-10", "https://www.nasdaq.com/articles/shire-shpg-hae-drug-gets-fda-nod-for-pediatric-population-2018-06-22", "https://www.nasdaq.com/articles/small-drugmakers-edging-out-bigshots-7-stocks-buy-2018-06-19", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-june-15th-2018-06-15", "https://www.nasdaq.com/articles/pre-market-most-active-may-24-2018-agnc-pbr-bp-bby-db-mlnt-tvix-mu-ge-chk-qqq-acrx-2018-05", "https://www.nasdaq.com/articles/health-care-sector-update-05242018-athncelgacrxkpti-2018-05-24", "https://www.nasdaq.com/articles/health-care-sector-update-05242018-celgacrxkpti-2018-05-24", "https://www.nasdaq.com/articles/vivus-pah-candidate-data-positive-in-early-stage-study-2018-07-11", "https://www.nasdaq.com/articles/wall-street-sees-mixed-open-us-gdp-climbs-more-expected-q1-2018-04-27", "https://www.nasdaq.com/articles/us-futures-mixed-ahead-us-gdp-reading-2018-04-27", "https://www.nasdaq.com/articles/earnings-reaction-history-acelrx-pharmaceuticals-inc-667-follow-through-indicator-104", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-acelrx-pharmaceuticals-acrx-stock-2018-03-07", "https://www.nasdaq.com/articles/omeros-inks-agreement-with-fda-for-oms721-phase-iii-trial-2018-01-04", "https://www.nasdaq.com/articles/trevena-announces-fda-acceptance-of-olinvo-nda-shares-up-2018-01-03", "https://www.nasdaq.com/articles/mercks-keytruda-gets-approved-for-bladder-cancer-in-japan-2018-01-03", "https://www.nasdaq.com/articles/top-ranked-momentum-stocks-to-buy-for-may-18th-2018-05-18", "https://www.nasdaq.com/articles/actinium-posts-positive-dmc-view-on-lomab-b-phase-iii-trial-2017-12-28", "https://www.nasdaq.com/articles/health-care-sector-update-10202017-qure-acrx-drrx-2017-10-20", "https://www.nasdaq.com/articles/health-care-sector-update-10202017-celgacrxdrrx-2017-10-20", "https://www.nasdaq.com/articles/acelrxs-opioid-painkiller-dsuvia-gets-crl-shares-plunge-2017-10-13", "https://www.nasdaq.com/articles/mid-day-market-update-jjill-tumbles-following-weak-q3-outlook-ardelyx-shares-surge-2017-10", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-jpmorgan-profit-beats-estimates-2017-10-12", "https://www.nasdaq.com/articles/pre-market-most-active-oct-12-2017-mu-azn-acrx-ardx-infi-jill-bac-c-gsk-snap-mnkd-tvix", "https://www.nasdaq.com/articles/5-reasons-to-pick-emergent-as-an-investment-worthy-stock-2018-01-03", "https://www.nasdaq.com/articles/health-care-sector-update-10122017-ardxinfiacrx-2017-10-12", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-inc-got-cut-half-today-2017-10-12", "https://www.nasdaq.com/articles/dow-returns-all-time-highs-2017-10-11", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-in-focus%3A-stock-moves-19.6-higher-2017-10-03", "https://www.nasdaq.com/articles/3-biotech-and-pharma-stocks-key-fda-catalysts-october-2017-10-02", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-inc-jumped-higher-today-2017-10-02", "https://www.nasdaq.com/articles/implied-volatility-surging-for-acelrx-pharmaceuticals-acrx-stock-options-2017-09-26", "https://www.nasdaq.com/articles/health-care-sector-update-10122017-ampeinfiacrx-2017-10-12", "https://www.nasdaq.com/articles/tuesday-sector-laggards-trucking-drugs-2017-08-01", "https://www.nasdaq.com/articles/monday-sector-leaders-biotechnology-drugs-2017-07-24", "https://www.nasdaq.com/articles/pre-market-most-active-jul-17-2017-ddc-sny-acrx-nvda-bac-tvix-baba-rad-mu-aprn-aapl-ntnx", "https://www.nasdaq.com/articles/health-care-sector-update-07172017-cbayacrxrprx-2017-07-17", "https://www.nasdaq.com/articles/health-care-sector-update-07172017-pphmacrxrprx-2017-07-17", "https://www.nasdaq.com/articles/5-biotech-stocks-major-catalysts-july-2017-06-28", "https://www.nasdaq.com/articles/mid-day-market-update-dow-drops-over-100-points-arena-pharmaceuticals-shares-plummet-2017", "https://www.nasdaq.com/articles/pre-market-most-active-aug-1-2017-mbly-uaa-ua-nok-mchi-acrx-s-bp-uslv-qqq-tvix-aapl-2017", "https://www.nasdaq.com/articles/tuesday-sector-laggards-trucking-drugs-2017-08-01", "https://www.nasdaq.com/articles/company-news-for-september-16-2016-2016-09-16", "https://www.nasdaq.com/articles/stock-futures-trim-gains-econ-data-fails-extinguish-rate-hike-jitters-2016-09-15", "https://www.nasdaq.com/articles/pre-market-most-active-sep-15-2016-aeg-aapl-azn-aeri-xiv-qqq-acrx-ttm-bac-tvix-nok-cs-2016", "https://www.nasdaq.com/articles/pre-market-most-active-aug-15-2016-baba-auph-yhoo-twtr-chk-vrx-x-twlo-acrx-xiv-acia-aapl", "https://www.nasdaq.com/articles/health-care-sector-update-08152016-acrx-adk-jnj-pfe-abt-mrk-amgn-2016-08-15", "https://www.nasdaq.com/articles/friday-sector-leaders-drugs-hospital-medical-practitioners-2017-03-03", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-in-focus%3A-stock-jumps-5.3-2016-08-04", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx%3A-strong-industry-solid-earnings-estimate-revisions-2016-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-03082016-omerbntcacrx-2016-03-08", "https://www.nasdaq.com/articles/health-care-sector-update-03082016-cdna-bntc-acrx-2016-03-08", "https://www.nasdaq.com/articles/earnings-reaction-history-acelrx-pharmaceuticals-inc-1000-follow-through-indicator-239", "https://www.nasdaq.com/articles/health-care-sector-update-01212016-agio-acrx-2016-01-21", "https://www.nasdaq.com/articles/acelrx-updates-on-zalviso-for-pain-management-treatment-2015-10-08", "https://www.nasdaq.com/articles/us-equities-set-positive-start-trading-week-2016-08-15", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-in-focus%3A-stock-jumps-5.3-2016-08-04", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-september-29th-2015-09-29", "https://www.nasdaq.com/articles/why-valeants-vrx-shares-plummeted-in-monday-trading-2015-09-29", "https://www.nasdaq.com/articles/pdl-biopharma-concludes-financing-agreement-with-avinger-2015-09-24", "https://www.nasdaq.com/articles/valeants-glaucoma-drug-accepted-for-review-by-the-fda-2015-09-23", "https://www.nasdaq.com/articles/acelrxs-pain-treatment-drug-zalviso-approved-in-europe-2015-09-23", "https://www.nasdaq.com/articles/pdl-biopharma-to-get-royalties-on-acelrxs-zalviso-sales-2015-09-22", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-october-1st-2015-10-01", "https://www.nasdaq.com/articles/pre-market-most-active-sep-9-2015-ttph-yhoo-aapl-acrx-xiv-alu-baba-tvix-bac-sune-bhp-nok", "https://www.nasdaq.com/articles/health-care-sector-update-09092015-rdhl-ast-acrx-2015-09-09", "https://www.nasdaq.com/articles/why-aceirx-acrx-could-be-a-potential-winner-2015-08-21", "https://www.nasdaq.com/articles/biocryst-pharmaceuticals-bcrx-jumps%3A-stock-rises-12.5-tale-of-the-tape-2015-08-11", "https://www.nasdaq.com/articles/concert-pharmaceuticals-cnce-in-focus%3A-stock-rises-5.2-tale-of-the-tape-2015-08-06", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-august-4th-tale-of-the-tape-2015-08-04", "https://www.nasdaq.com/articles/notable-etf-outflow-detected-bib-acad-xlrn-acrx-2015-07-21", "https://www.nasdaq.com/articles/why-you-shouldnt-bet-against-aceirx-pharmaceuticals-acrx-stock-2015-09-10", "https://www.nasdaq.com/articles/can-the-rally-in-acelrx-pharmaceuticals-acrx-shares-continue-tale-of-the-tape-2015-06-03", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-looks-good%3A-stock-up-8-tale-of-the-tape-2015-05-15", "https://www.nasdaq.com/articles/health-care-sector-update-05142015-acrx-dsco-eprs-2015-05-14", "https://www.nasdaq.com/articles/tuesday-sector-laggards-drugs-paper-forest-products-2015-05-05", "https://www.nasdaq.com/articles/acelrx-starts-pivotal-study-on-acute-pain-management-drug-analyst-blog-2015-03-17", "https://www.nasdaq.com/articles/health-care-sector-update-03162015-nby-slxp-acrx-2015-03-16", "https://www.nasdaq.com/articles/health-care-sector-update-03102015-acrx-vrx-rdus-2015-03-10", "https://www.nasdaq.com/articles/health-care-sector-update-07022015-navb-amsg-acrx-2015-07-02", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-inc-stock-got-crushed-2015-03-09", "https://www.nasdaq.com/articles/why-medicines-company-tumbling-2015-03-09", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-9-2015-urbn-qihu-unfi-casy-mr-kfy-vnet-xoxo-acrx-wprt", "https://www.nasdaq.com/articles/should-you-sell-acelrx-pharmaceuticals-acrx-before-earnings-tale-of-the-tape-2015-03-06", "https://www.nasdaq.com/articles/health-care-sector-update-02262015-mack-mgln-acrx-2015-02-26", "https://www.nasdaq.com/articles/acelrx-acrx-shares-march-higher-can-it-continue-tale-of-the-tape-2015-01-12", "https://www.nasdaq.com/articles/why-acelrx-pharmaceuticals-inc-crashing-2015-03-10", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2015-01-05", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-12-29", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-12-18", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/la-jolla-pharmaceutical-ljpc-jumps%3A-stock-gains-5.8-tale-of-the-tape-2014-12-15", "https://www.nasdaq.com/articles/health-care-sector-update-12022014-gwph-acrx-gale-2014-12-02", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-11-20", "https://www.nasdaq.com/articles/minerva-neurosciences-nerv-in-focus%3A-stock-jumps-8.2-tale-of-the-tape-2015-01-07", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2015-01-05", "https://www.nasdaq.com/articles/arqule-arql-catches-eye%3A-stock-jumps-10.4-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-soars%3A-stock-adds-6.8-in-session-tale-of-the-tape-2014-08-01", "https://www.nasdaq.com/articles/pre-market-most-active-jul-28-2014-fdo-dltr-acrx-hznp-trla-loco-sny-dg-bhp-gsk-fb-aapl", "https://www.nasdaq.com/articles/monday-sector-laggards-metals-fabrication-products-drugs-2014-07-28", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-jumps%3A-stock-adds-11.7-in-session-tale-of-the-tape-2014-07-21", "https://www.nasdaq.com/articles/friday-sector-leaders-manufacturing-drugs-2014-07-18", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-edge-lower-dr-horton-posts-downbeat-profit-2014-11-11", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-tuesday-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/arqule-arql-catches-eye%3A-stock-jumps-10.4-tale-of-the-tape-2014-11-11", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-soars%3A-stock-adds-6.8-in-session-tale-of-the-tape-2014-08-01", "https://www.nasdaq.com/articles/pre-market-most-active-jul-28-2014-fdo-dltr-acrx-hznp-trla-loco-sny-dg-bhp-gsk-fb-aapl", "https://www.nasdaq.com/articles/monday-sector-laggards-metals-fabrication-products-drugs-2014-07-28", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-jumps%3A-stock-up-17.9-tale-of-the-tape-2013-12-17", "https://www.nasdaq.com/articles/acelrx-pharmaceuticals-acrx-jumps%3A-stock-rises-9.0-tale-of-the-tape-2014-06-17", "https://www.nasdaq.com/articles/insider-trading-sales-google-facebook-and-whole-foods-buys-agco-and-vivus-2013-11-13", "https://www.nasdaq.com/articles/insider-trading-buys-freeport-mcmoran-horsehead-holding-acelrx-2013-11-05", "https://www.nasdaq.com/articles/acelrx-gives-patent-update-analyst-blog-2013-10-09", "https://www.nasdaq.com/articles/after-hours-earnings-report-august-12-2013-sina-trq-ioc-iag-wx-hmin-twgp-egl-ccxi-fn-nq", "https://www.nasdaq.com/articles/insider-trading-apollo-management-group-makes-two-major-sales-while-ebay-sees-purchase", "https://www.nasdaq.com/articles/pre-market-most-active-may-21-2013-jaso-msft-sdbt-amat-acrx-csiq-2013-05-21", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx", "https://www.nasdaq.com/articles/nda-for-acelrxs-zalviso-accepted-analyst-blog-2013-12-05", "https://www.nasdaq.com/articles/synergy-callisto-merger-approved-analyst-blog-2013-01-17", "https://www.nasdaq.com/articles/fda-approval-for-santarus-uceris-analyst-blog-2013-01-18"], "Content": []}